DM-1992: Phase I started

Depomed began an open-label, crossover, Russian Phase I trial in 18 patients to compare 2 formulations of oral DM-1992 vs. Sinemet CR levodopa/carbidopa from Bristol-Myers Squibb Co. (NYSE:BMY, New Y...